ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Meeting Management Challenges in axSpA

Thomas R. Collins  |  November 1, 2025

Malignancies with spine infiltration, such as B cell lymphoma or acute lymphocytic leukemia, can also masquerade as axSpA, Dr. Gensler said.

Other mimics to watch out for include diffuse idiopathic skeletal hyperostosis (DISH); Scheurmann’s disease, involving an abnormal and excessive curvature of the spine; and Bertolotti syndrome, involving an extra bone between the last lumbar bone and the sacrum, Dr. Gensler said. Clinicians should also be aware of the possibility of sacral insufficiency fractures, spinal fractures and infections.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Gensler said clinicians should keep a list of pointers in mind so as not to fall into the axSpA trap. First, inflammatory back pain does not necessarily equal axSpA, even when other suggestive features are present; clinical context and concordant imaging are needed. Second, clinicians should read MRIs “like a detective,” on the lookout for other diagnoses. Third, a stress reaction and cortical irregularity don’t necessarily add up to the presence of sacroiliitis. Fourth, clinicians should have a list of diagnoses they “can’t miss,” including infections, malignancies and fractures.

Lastly, she said, it’s important to keep in mind that Hickam’s dictum—that “patients can have as many diseases as they damn well please”—often supersedes Occam’s razor, the idea that the simplest explanation is usually the best.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“The law of simplicity to explain everything,” Dr. Gensler said, “doesn’t always work.”


Thomas R. Collins is a freelance medical writer based in Florida.

References

  1. Maksymowych WP, van der Heijde D, Caplan L, et al. The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) Revised Classification Criteria for Axial Spondyloarthritis: Development and validation in the classification of axial SpA inception cohort study [abstract 0854]. Arthritis Rheumatol. 2025;77(suppl 9).
  2. Weiss PF, Brandon TG, Aggarwal A, et al. Classification criteria for axial disease in youth with juvenile spondyloarthritis. Arthritis Rheumatol. 2024 Dec;76(12):1797–1808.
  3. Children’s Hospital of Philadelphia. Axial Juvenile [PF3] Spondyloarthritis (AxJSpA) Classification Criteria Calculator. https://redcap.chop.edu/surveys/?s=D3CXKYTRL4M87XM8. Accessed October 31, 2025.
  4. Gensler LS, Ward MM, Reveille JD, et al. Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort. Ann Rheum Dis. 2008 Feb;67(2):233–237.

 

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting Reports Tagged with:ACR Convergence 2025ACR Convergence 2025 - PsAaxial juvenile spondyloarthritisaxial spondyloarthritis (SpA)

Related Articles
    Andrew Brookes / Image Source on Offset

    Clinical Insights into Axial Spondyloarthritis: Rheumatology Drugs at a Glance, Part 5

    February 10, 2022

    Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options; others have few or only off-label options. This series, Rheumatology Drugs at a Glance, provides streamlined information on the administration of biologic, biosimilar and other medications used to…

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

    Key Research in Axial Spondyloarthritis Encapsulated

    December 2, 2024

    Our understanding of (axSpA) has really changed, especially with regard to male-female differences. In this report, we identify important research on axSpA presented at ACR Convergence 2024, summarize the abstracts and comment on why each is important, addressing the relevance for clinicians and the potential impact on future research.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences